According to a recent LinkedIn post from PIUR IMAGING, the company is actively engaging with medical professionals at the DGN conference in Münster. The post highlights strong interest in PIUR tUS Infinity, its tomographic 3D ultrasound solution focused on thyroid and endocrine applications.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests that PIUR IMAGING is positioning its AI-driven ultrasound technology within nuclear medicine, endocrinology, and endocrine surgery workflows. For investors, this visibility and clinician interaction may indicate growing market awareness and potential demand in specialized diagnostic segments, which could support future adoption and revenue growth if interest translates into commercial deployments.